BriaCell Therapeutics (BCTX) SEC Filings & 10K Form

$2.24
+0.05 (+2.28%)
(As of 03:59 PM ET)

Recent BriaCell Therapeutics SEC Filings

DateFilerForm TypeView
03/18/2024
4:15 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/31/2024
11:15 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form EFFECT
01/31/2024
4:24 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
4:00 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2024
10:01 AM
BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
Copia Fund LP (0001718996) (Filed by)
Form SCHEDULE 13G
11/30/2023
6:00 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
7:45 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2023
4:25 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2023
4:26 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/08/2023
7:49 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
3:30 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:25 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:43 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
3:52 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
3:30 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form PRE 14A
06/27/2023
8:30 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
4:18 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/22/2023
10:48 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BCTX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners